Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 13 studies | 31% ± 12% | |
peripheral blood | 9 studies | 20% ± 4% | |
intestine | 7 studies | 24% ± 11% | |
kidney | 7 studies | 23% ± 6% | |
brain | 5 studies | 25% ± 7% | |
eye | 4 studies | 19% ± 4% | |
uterus | 4 studies | 32% ± 10% | |
breast | 4 studies | 23% ± 2% | |
liver | 4 studies | 30% ± 19% | |
pancreas | 3 studies | 56% ± 18% | |
adrenal gland | 3 studies | 18% ± 3% | |
lymph node | 3 studies | 30% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 18463.72 | 1445 / 1445 | 100% | 150.61 | 183 / 183 |
skin | 100% | 21716.64 | 1808 / 1809 | 100% | 247.21 | 472 / 472 |
kidney | 100% | 15065.93 | 89 / 89 | 100% | 239.54 | 899 / 901 |
ovary | 100% | 19185.74 | 180 / 180 | 100% | 96.01 | 429 / 430 |
prostate | 100% | 17650.67 | 245 / 245 | 99% | 150.69 | 499 / 502 |
thymus | 100% | 15647.23 | 650 / 653 | 100% | 106.03 | 604 / 605 |
uterus | 100% | 19903.36 | 170 / 170 | 99% | 114.54 | 456 / 459 |
intestine | 100% | 15552.46 | 966 / 966 | 99% | 111.20 | 523 / 527 |
liver | 100% | 13765.68 | 225 / 226 | 100% | 134.86 | 404 / 406 |
adrenal gland | 100% | 26589.43 | 258 / 258 | 99% | 171.72 | 227 / 230 |
breast | 100% | 25313.50 | 459 / 459 | 98% | 114.28 | 1100 / 1118 |
lung | 100% | 19116.39 | 576 / 578 | 99% | 138.68 | 1140 / 1155 |
stomach | 100% | 13435.59 | 359 / 359 | 98% | 128.83 | 281 / 286 |
bladder | 100% | 19842.10 | 21 / 21 | 97% | 109.46 | 491 / 504 |
brain | 97% | 9471.47 | 2570 / 2642 | 100% | 147.51 | 705 / 705 |
pancreas | 63% | 3574.60 | 206 / 328 | 100% | 152.46 | 178 / 178 |
adipose | 100% | 32146.00 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 49541.78 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 182.56 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 84.35 | 29 / 29 |
spleen | 100% | 9376.41 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 111.18 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 118.06 | 1 / 1 |
heart | 99% | 20720.29 | 854 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 10547.73 | 790 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 84% | 5922.63 | 782 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006809 | Biological process | nitric oxide biosynthetic process |
GO_0008015 | Biological process | blood circulation |
GO_0006695 | Biological process | cholesterol biosynthetic process |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0005811 | Cellular component | lipid droplet |
GO_0005833 | Cellular component | hemoglobin complex |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005737 | Cellular component | cytoplasm |
GO_1903958 | Cellular component | nitric-oxide synthase complex |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0043531 | Molecular function | ADP binding |
GO_0071949 | Molecular function | FAD binding |
GO_0051287 | Molecular function | NAD binding |
GO_0004128 | Molecular function | cytochrome-b5 reductase activity, acting on NAD(P)H |
GO_0016208 | Molecular function | AMP binding |
GO_0050421 | Molecular function | nitrite reductase (NO-forming) activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CYB5R3 |
Protein name | cytochrome-b5 reductase (EC 1.6.2.2) NADH-cytochrome b5 reductase 3 (B5R) (Cytochrome b5 reductase) (EC 1.6.2.2) (Diaphorase-1) NADH-cytochrome b5 reductase (EC 1.6.2.2) Cytochrome b5 reductase 3 |
Synonyms | hCG_41905 DIA1 |
Description | FUNCTION: Catalyzes the reduction of two molecules of cytochrome b5 using NADH as the electron donor. . FUNCTION: Catalyzes the reduction of two molecules of cytochrome b5 using NADH as the electron donor. . FUNCTION: Catalyzes the reduction of two molecules of cytochrome b5 using NADH as the electron donor. . |
Accessions | A0A8J8YWN6 ENST00000686129.1 ENST00000688244.1 ENST00000407332.6 ENST00000693157.1 A0A8I5KUA5 ENST00000407623.8 [P00387-2] A0A8I5KPU0 ENST00000688117.1 [P00387-3] A0A8I5KYU1 A0A8I5KXI5 ENST00000687198.1 [P00387-2] A0A8I5QKL2 ENST00000689195.1 A0A8I5KR71 ENST00000352397.10 [P00387-1] ENST00000402438.6 [P00387-2] ENST00000438270.2 ENST00000693363.1 ENST00000693639.1 ENST00000686523.1 A0A8I5KTF9 ENST00000693646.1 ENST00000693367.1 A0A8J8Z3C6 ENST00000691295.1 B1AHF3 ENST00000691918.1 A0A8I5QKX1 ENST00000690835.1 ENST00000361740.9 A0A8I5KVD2 A0A8I5KNV1 ENST00000692152.1 [P00387-2] P00387 A0A8I5QKT9 A0A8I5KW26 |